A Day Up For Oncorus Inc.
Wed, Nov 16, 2022 at 07:29 PM
Oncorus Inc. (ONCR:NASDAQ) soared at $0.62, a gain of 18.6%. On Wed, Nov 16, 2022, ONCR:NASDAQ touched a New 2-Week Intraday High of $0.7. The stock appeared on our News Catalysts scanner on Wed, Nov 02, 2022 at 08:37 AM in the 'INVESTOR UPDATE' category. From Wed, Nov 02, 2022, the stock recorded 40.00% Up Days and 18.18% Green Days
The stock spiked on Tue, Jun 07, 2022 at $1.9 with a volume of 4M+.
About Oncorus Inc. (ONCR:NASDAQ)
Oncorus Inc is a clinical stage biopharmaceutical company focused on developing viral immunotherapies to transform outcomes for cancer patients.
Top 10 Gainers:
- Fast Radius Inc. (FSRD:NASDAQ), 106.29%
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 36.33%
- Foresight Autonomous Holdings Ltd. (FRSX:NASDAQ), 33.04%
- XL Group Ltd (XL:NYSE), 30.91%
- Ensysce Biosciences Inc. (ENSC:NASDAQ), 29.17%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 28.32%
- Creatd Inc. (CRTD:NASDAQ), 22.12%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 21.99%
- BYND Cannasoft Enterprises Inc. (BCAN:NASDAQ), 19.67%
- Oncorus Inc. (ONCR:NASDAQ), 18.61%